Doubleview Surpasses 7,500m This Season Diamond Drill Coring at the Hat Polymetallic Deposit
Vancouver, British Columbia–(ACN Newswire – September 11, 2023) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
Vancouver, British Columbia–(ACN Newswire – September 11, 2023) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
SAN DIEGO–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology…
Proprietary operating system gives Viral Nation customers a competitive advantage through centralized talent discovery, management…
MIAMI–(BUSINESS WIRE)–Bird Global, Inc. (NYSE:BRDS), a leader in environmentally friendly electric transportation, today announced the…
New grants will benefit high schools and middle schools in cities across the United States…
PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
MBX 2109 was observed to be generally well-tolerated MBX 2109 increased albumin adjusted serum calcium…